FDA Inspection 1027413 — Center for Fertility and Reproductive Endocrinology UPP
The FDA completed an inspection of Center for Fertility and Reproductive Endocrinology UPP on August 29, 2017 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 29, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pittsburgh, PA (United States)